Litcius/Paper detail

Pretomanid: The latest USFDA-approved anti-tuberculosis drug

Uttiya Deb, Supreeti Biswas

2020Indian Journal of Tuberculosis20 citationsDOI

Topics & Concepts

BedaquilineLinezolidRegimenDrugMedicineTuberculosisPharmacologyAdverse effectMycobacterium tuberculosisInternal medicineBiologyPathologyBacteriaVancomycinGeneticsStaphylococcus aureusTuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisPneumonia and Respiratory Infections
Pretomanid: The latest USFDA-approved anti-tuberculosis drug | Litcius